You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亞香股份(301220.SZ):公司於2023年搭建完成了合成生物學的團隊
格隆匯 05-09 09:22

格隆匯5月9日丨亞香股份(301220.SZ)在上公司2023年年度業績説明會上表示,公司於2023年搭建完成了合成生物學的團隊,該團隊由畢業於江南大學的陳博士作為公司合成生物學項目帶頭人,進行相關合成生物方面的研究。此外公司也通過高校以及一些外部生物研發公司合作進行相關產品的開發。

目前公司新建的研發大樓基本上已完工,我們搭建了1,200平方米的合成生物學實驗室。未來,公司將會與合成生物學領域的專家、院士等通過建立聯合實驗室的方式將合成生物學的技術應用到香精香料當中。通過合成生物學的研發,未來除了能幫助公司開發出更多的香料品類以外,還可以將現有的產品成本進行降低,進而達到增加公司銷售額,降低產品的成本以增加公司業績的作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account